Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


Articles published in BMC Neurol

Retrieve available abstracts of 27 articles:
HTML format
Text format



Single Articles


    February 2017
  1. TAI SY, Chen CH, Chien CY, Yang YH, et al
    Cilostazol as an add-on therapy for patients with Alzheimer's disease in Taiwan: a case control study.
    BMC Neurol. 2017;17:40.
    PubMed     Text format     Abstract available


    January 2017
  2. LI F, Chen S, Wei C, Jia J, et al
    Monetary costs of Alzheimer's disease in China: protocol for a cluster-randomised observational study.
    BMC Neurol. 2017;17:15.
    PubMed     Text format     Abstract available


    November 2016
  3. SHAFI O
    Inverse relationship between Alzheimer's disease and cancer, and other factors contributing to Alzheimer's disease: a systematic review.
    BMC Neurol. 2016;16:236.
    PubMed     Text format     Abstract available


  4. DEMING Y, Black K, Carrell D, Cai Y, et al
    Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40.
    BMC Neurol. 2016;16:217.
    PubMed     Text format     Abstract available


    August 2016
  5. SCHONECKER S, Brendel M, Huber M, Vollmar C, et al
    Applied multimodal diagnostics in a case of presenile dementia.
    BMC Neurol. 2016;16:131.
    PubMed     Text format     Abstract available


    June 2016
  6. BLANCO MARTIN E, Ugarriza Serrano I, Elcoroaristizabal Martin X, Galdos Alcelay L, et al
    Dysexecutive syndrome in amnesic mild cognitive impairment: a multicenter study.
    BMC Neurol. 2016;16:88.
    PubMed     Text format     Abstract available


    May 2016
  7. CHEN GQ, Sheng C, Li YX, Yu Y, et al
    Neuroimaging basis in the conversion of aMCI patients with APOE-epsilon4 to AD: study protocol of a prospective diagnostic trial.
    BMC Neurol. 2016;16:64.
    PubMed     Text format     Abstract available


    January 2016
  8. AN SS, Bagyinszky E, Kim HR, Seok JW, et al
    Novel PSEN1 G209A mutation in early-onset Alzheimer dementia supported by structural prediction.
    BMC Neurol. 2016;16:71.
    PubMed     Text format     Abstract available


  9. MCGHEE DJ, Ritchie CW, Zajicek JP, Counsell CE, et al
    A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer's disease and Parkinson's disease.
    BMC Neurol. 2016;16:92.
    PubMed     Text format     Abstract available


  10. ZHAO L, Chen T, Wang C, Li G, et al
    Atorvastatin in improvement of cognitive impairments caused by amyloid beta in mice: involvement of inflammatory reaction.
    BMC Neurol. 2016;16:18.
    PubMed     Text format     Abstract available


  11. WATTMO C, Londos E, Minthon L
    Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease: a prospective, observational study of factors affecting survival time from admission to death.
    BMC Neurol. 2016;16:156.
    PubMed     Text format     Abstract available


  12. BERGE G, Sando SB, Albrektsen G, Lauridsen C, et al
    Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer's disease, mild cognitive impairment, or healthy controls: a two year follow-up study.
    BMC Neurol. 2016;16:180.
    PubMed     Text format     Abstract available


    December 2015
  13. LONG AN, Owens K, Schlappal AE, Kristian T, et al
    Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer's disease-relevant murine model.
    BMC Neurol. 2015;15:272.
    PubMed     Text format     Abstract available


  14. LIU D, Zhang L, Li Z, Zhang X, et al
    Thinner changes of the retinal nerve fiber layer in patients with mild cognitive impairment and Alzheimer's disease.
    BMC Neurol. 2015;15:268.
    PubMed     Text format     Abstract available


    March 2015
  15. YOKOYAMA JS, Bonham LW, Sears RL, Klein E, et al
    Decision Tree Analysis of Genetic Risk for Clinically Heterogeneous Alzheimer's Disease.
    BMC Neurol. 2015;15:47.
    PubMed     Text format     Abstract available


    February 2015
  16. SILAJD I E, Bjorkqvist M, Hansson O
    Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer inverted question marks disease.
    BMC Neurol. 2015;15:8.
    PubMed     Text format     Abstract available


    January 2015
  17. LIU D, Zhang L, Li Z, Zhang X, et al
    Thinner changes of the retinal nerve fiber layer in patients with mild cognitive impairment and Alzheimer's disease.
    BMC Neurol. 2015;15:14.
    PubMed     Text format     Abstract available


  18. LONG AN, Owens K, Schlappal AE, Kristian T, et al
    Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer's disease-relevant murine model.
    BMC Neurol. 2015;15:19.
    PubMed     Text format     Abstract available


  19. ROTOMSKIS A, Margeviciute R, Germanavicius A, Kaubrys G, et al
    Differential diagnosis of depression and Alzheimer's disease with the Addenbrooke's Cognitive Examination-Revised (ACE-R).
    BMC Neurol. 2015;15:57.
    PubMed     Text format     Abstract available


  20. JEONG JH, Yum KS, Chang JY, Kim M, et al
    Dose-specific effect of simvastatin on hypoxia-induced HIF-1alpha and BACE expression in Alzheimer's disease cybrid cells.
    BMC Neurol. 2015;15:127.
    PubMed     Text format     Abstract available


  21. ENGELS MM, Stam CJ, van der Flier WM, Scheltens P, et al
    Declining functional connectivity and changing hub locations in Alzheimer's disease: an EEG study.
    BMC Neurol. 2015;15:145.
    PubMed     Text format     Abstract available


  22. SCHROETER ML, Tiepolt S, Marschhauser A, Thone-Otto A, et al
    Dissociation of amyloid biomarkers in PET and CSF in Alzheimer's disease: a case report.
    BMC Neurol. 2015;15:152.
    PubMed     Text format     Abstract available


  23. MEGURO K, Akanuma K, Meguro M, Kasai M, et al
    Lifetime expectancy and quality-adjusted life-year in Alzheimer's disease with and without cerebrovascular disease: effects of nursing home replacement and donepezil administration - a retrospective analysis in the Tajiri Project.
    BMC Neurol. 2015;15:227.
    PubMed     Text format     Abstract available


  24. MANCINI M, Fling BW, Gendreau A, Lapidus J, et al
    Effect of augmenting cholinergic function on gait and balance.
    BMC Neurol. 2015;15:264.
    PubMed     Text format     Abstract available


  25. CYSIQUE LA, Hewitt T, Croitoru-Lamoury J, Taddei K, et al
    APOE epsilon4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study.
    BMC Neurol. 2015;15:51.
    PubMed     Text format     Abstract available


    December 2014
  26. MEGURO K, Ouchi Y, Akanuma K, Meguro M, et al
    Donepezil can improve daily activities and promote rehabilitation for severe Alzheimer inverted question marks patients in long-term care health facilities.
    BMC Neurol. 2014;14:243.
    PubMed     Text format     Abstract available


    November 2014
  27. LI JM, Liu C, Hu X, Cai Y, et al
    Inverse correlation between Alzheimer inverted question marks disease and cancer: implication for a strong impact of regenerative propensity on neurodegeneration?
    BMC Neurol. 2014;14:211.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: